Semaglutide, the active ingredient in medications like Wegovy, Ozempic, and Rybelsus, works by mimicking a naturally occurring hormone in your body called glucagon-like peptide-1 (GLP-1)
Se toma disuelto en agua
Maybe two dozen
SURPASS-CVOT is a phase 3 study enrolled approximately 13,000 patients at least 40 years of age and have a diagnosis of type 2 diabetes, confirmed atherosclerotic cardiovascular disease, HbA1c 7.0% to 10.5% and a body mass index (BMI) 25 kilograms per meter squared (kg/m 2 )
If you want an in-depth take on risks and what labs/appointments to expect you can go through the FDA medication guide and MedlinePlus overview
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results